| Sponsor |
Protocol Code |
Trial Name |
Principal Investigator |
Phase |
Therapeutic Area |
Diseases and Conditions |
| Sanofi |
EFC17504 |
A randomized, double-blind, Phase 3 study comparing efficacy and safety of frexalimab (SAR441344) to placebo in adult participants with nonrelapsing secondary progressive multiple sclerosis. |
AYŞE ALTINTAŞ (Prof.Dr.) |
Phase 3 |
Neurology |
Multiple Sclerosis |
| Stoparkinson |
STP-PD-006 |
Multicenter Study of Safety and Effectiveness of Auricular Muscle Zone
Stimulation with the EarStim Novel Device for Parkinson’s disease |
SİBEL ERTAN (Prof.Dr.) |
Medical Device |
Neurology |
Parkinson’s |
| Dianthus Therapeutics, Inc |
DNTH103‑CIDP‑301 |
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to
Evaluate the Efficacy and Safety of DNTH103 in Adults with Chronic
Inflammatory Demyelinating Polyneuropathy (CAPTIVATE) |
PİRAYE OFLAZER (Prof.Dr.) |
Phase 2 |
Neurology |
Polyneuropathy |
| Dianthus Therapeutics, Inc |
MOMENTUM |
A Phase 2, Randomized, Double-Blinded, Placebo-Controlled, Study to Evaluate Safety, Tolerability, Pharmacometrics, and Efficacy of DNTH103 in Adults with Multifocal Motor Neuropathy (MOMENTUM) |
PİRAYE OFLAZER (Prof.Dr.) |
Phase 2 |
Neurology |
Multifocal Motor Neuropathy |